Follow
Ronald Hall
Ronald Hall
Associate Professor of Pharmacy Practice, Texas Tech University HSC
Verified email at ttuhsc.edu - Homepage
Title
Cited by
Cited by
Year
Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?
KA Hazlewood, SD Brouse, WD Pitcher, RG Hall
The American journal of medicine 123 (2), 182. e1-182. e7, 2010
1832010
Atazanavir for the treatment of human immunodeficiency virus infection
AJ Busti, RG Hall, DM Margolis
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 24 (12 …, 2004
1392004
Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin
AJ Busti, AM Bain, RG Hall, RG Bedimo, RD Leff, C Meek, R Mehvar
Journal of cardiovascular pharmacology 51 (6), 605-610, 2008
1302008
Treatment of active pulmonary tuberculosis in adults: current standards and recent advances: insights from the Society of Infectious Diseases Pharmacists
RG Hall, RD Leff, T Gumbo
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (12 …, 2009
1012009
Clinical and microbiologic analysis of a hospital's extended‐spectrum β‐lactamase‐producing isolates over a 2‐year period
DS Burgess, RG Hall, JS Lewis, JH Jorgensen, JE Patterson
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 23 (10 …, 2003
992003
Use of vancomycin pharmacokinetic–pharmacodynamic properties in the treatment of MRSA infections
C Giuliano, KK Haase, R Hall
Expert review of anti-infective therapy 8 (1), 95-106, 2010
872010
Multicenter evaluation of vancomycin dosing: emphasis on obesity
RG Hall II, KD Payne, AM Bain, AP Rahman, ST Nguyen, SA Eaton, ...
The American journal of medicine 121 (6), 515-518, 2008
842008
In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae
DS Burgess, RG Hall II
Diagnostic microbiology and infectious disease 49 (1), 41-46, 2004
802004
Fractal geometry and the pharmacometrics of micafungin in overweight, obese, and extremely obese people
RG Hall, MA Swancutt, T Gumbo
Antimicrobial agents and chemotherapy 55 (11), 5107-5112, 2011
622011
Infectious Diseases: Pharmacologic Treatment Options for Nosocomial Pneumonia Involving Methicillin-Resistant Staphylococcus aureus
DO Maclayton, RG Hall
Annals of Pharmacotherapy 41 (2), 235-244, 2007
622007
Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths
RG Hall, MA Swancutt, C Meek, R Leff, T Gumbo
Antimicrobial agents and chemotherapy 57 (5), 2259-2264, 2013
532013
Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia …
RG Hall, KA Hazlewood, SD Brouse, CA Giuliano, KK Haase, CR Frei, ...
BMC Pharmacology and Toxicology 14, 1-6, 2013
512013
Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people
RG Hall, MA Swancutt, C Meek, RD Leff, T Gumbo
Antimicrobial agents and chemotherapy 56 (3), 1502-1507, 2012
442012
Dosing considerations for obese patients receiving cancer chemotherapeutic agents
RG Hall, GW Jean, M Sigler, S Shah
Annals of Pharmacotherapy 47 (12), 1666-1674, 2013
412013
In vitro evaluation of the activity of two doses of levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa
DS Burgess, RG Hall, TC Hardin
Diagnostic microbiology and infectious disease 46 (2), 131-137, 2003
402003
Evaluation of chemotherapy-induced severe myelosuppression incidence in obese patients with capped dosing
MD Lopes-Serrao, SMG Ussery, RG Hall, SR Shah
Journal of Oncology Practice 7 (1), 13-17, 2011
392011
Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
RG Hall, CA Giuliano, KK Haase, KA Hazlewood, CR Frei, NA Forcade, ...
BMC Infectious Diseases 12, 1-5, 2012
372012
Dosing of antifungal agents in obese people
KD Payne, RG Hall
Expert review of anti-infective therapy 14 (2), 257-267, 2016
362016
Dosing of antibacterial agents in obese adults: does one size fit all?
KD Payne, RG Hall
Expert Review of Anti-infective Therapy 12 (7), 829-854, 2014
352014
Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind
A Arnold, SD Brouse, WD Pitcher, RG Hall
Journal of intensive care medicine 25 (5), 259-270, 2010
292010
The system can't perform the operation now. Try again later.
Articles 1–20